CO2023005368A2 - Composiciones de relleno de liberación controlada y cápsulas que contienen las mismas - Google Patents

Composiciones de relleno de liberación controlada y cápsulas que contienen las mismas

Info

Publication number
CO2023005368A2
CO2023005368A2 CONC2023/0005368A CO2023005368A CO2023005368A2 CO 2023005368 A2 CO2023005368 A2 CO 2023005368A2 CO 2023005368 A CO2023005368 A CO 2023005368A CO 2023005368 A2 CO2023005368 A2 CO 2023005368A2
Authority
CO
Colombia
Prior art keywords
controlled release
daltons
weight
filler composition
soft
Prior art date
Application number
CONC2023/0005368A
Other languages
English (en)
Spanish (es)
Inventor
Qi Fang
Karunakar Sukuru
Original Assignee
Scherer Technologies Llc R P
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scherer Technologies Llc R P filed Critical Scherer Technologies Llc R P
Publication of CO2023005368A2 publication Critical patent/CO2023005368A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4833—Encapsulating processes; Filling of capsules

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CONC2023/0005368A 2020-10-16 2023-04-27 Composiciones de relleno de liberación controlada y cápsulas que contienen las mismas CO2023005368A2 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202063092679P 2020-10-16 2020-10-16
PCT/US2021/054991 WO2022081848A1 (en) 2020-10-16 2021-10-14 Controlled release fill compositions and capsules containing same

Publications (1)

Publication Number Publication Date
CO2023005368A2 true CO2023005368A2 (es) 2023-05-19

Family

ID=81209315

Family Applications (1)

Application Number Title Priority Date Filing Date
CONC2023/0005368A CO2023005368A2 (es) 2020-10-16 2023-04-27 Composiciones de relleno de liberación controlada y cápsulas que contienen las mismas

Country Status (13)

Country Link
US (1) US20230372252A1 (cg-RX-API-DMAC7.html)
EP (1) EP4228608A4 (cg-RX-API-DMAC7.html)
JP (1) JP7874626B2 (cg-RX-API-DMAC7.html)
KR (1) KR20230088730A (cg-RX-API-DMAC7.html)
CN (1) CN116367864A (cg-RX-API-DMAC7.html)
AR (1) AR123800A1 (cg-RX-API-DMAC7.html)
AU (2) AU2021360905B2 (cg-RX-API-DMAC7.html)
CA (1) CA3195386A1 (cg-RX-API-DMAC7.html)
CO (1) CO2023005368A2 (cg-RX-API-DMAC7.html)
IL (1) IL301692A (cg-RX-API-DMAC7.html)
MX (1) MX2023004441A (cg-RX-API-DMAC7.html)
TW (1) TW202228655A (cg-RX-API-DMAC7.html)
WO (1) WO2022081848A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20240099982A1 (en) * 2022-09-27 2024-03-28 Gaia Herbs Cellulose derivative free capsule for herbal extracts

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5406530B2 (ja) * 2005-10-26 2014-02-05 バナー ファーマキャプス， インコーポレイテッド 親水性ベヒクルに基づく二重制御された放出マトリクスシステム
US10960077B2 (en) * 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
CA2850853A1 (en) * 2011-10-06 2013-04-11 Grunenthal Gmbh Tamper-resistant oral pharmaceutical dosage form comprising opioid agonist and opioid antagonist
WO2015200149A1 (en) * 2014-06-23 2015-12-30 Banner Life Sciences Llc All natural enteric soft capsules comprising active ingredients
CA2978269A1 (en) * 2015-03-02 2016-09-09 Bionpharma Healthcare Llc Immediate release soluble ibuprofen compositions
WO2016170097A1 (en) * 2015-04-24 2016-10-27 Grünenthal GmbH Tamper-resistant dosage form with immediate release and resistance against solvent extraction
MX2017013634A (es) * 2015-04-24 2018-03-08 Gruenenthal Gmbh Combinacion de dosis fija resistente a la manipulacion que proporciona una liberacion rapida de dos farmacos desde particulas y un polvo.
US9943513B1 (en) * 2015-10-07 2018-04-17 Banner Life Sciences Llc Opioid abuse deterrent dosage forms
WO2020068510A1 (en) * 2018-09-25 2020-04-02 SpecGx LLC Abuse deterrent immediate release capsule dosage forms

Also Published As

Publication number Publication date
IL301692A (en) 2023-05-01
US20230372252A1 (en) 2023-11-23
JP2023545494A (ja) 2023-10-30
JP7874626B2 (ja) 2026-06-16
AU2021360905A9 (en) 2024-10-10
KR20230088730A (ko) 2023-06-20
EP4228608A1 (en) 2023-08-23
NZ799086A (en) 2026-02-27
WO2022081848A1 (en) 2022-04-21
CA3195386A1 (en) 2022-04-21
AR123800A1 (es) 2023-01-11
AU2026201700A1 (en) 2026-03-26
AU2021360905A1 (en) 2023-06-01
EP4228608A4 (en) 2024-10-02
MX2023004441A (es) 2023-05-08
AU2021360905B2 (en) 2026-01-08
CN116367864A (zh) 2023-06-30
TW202228655A (zh) 2022-08-01

Similar Documents

Publication Publication Date Title
ES2206081T1 (es) Procedimiento para preparar composiciones farmaceuticas para uso con formulaciones de gelatina blanda.
PE20061136A1 (es) Sistema de capsulas blandas que no son de gelatina
ES2002302A6 (es) Una capsula de gelatina dura que contiene una composicion masticable
AR110986A2 (es) Composiciones de ecteinascidina, formulaciones liofilizadas, método de preparación y uso
Hegde et al. Sealing ability of a novel hydrophilic vs. conventional hydrophobic obturation systems: A bacterial leakage study
AR036943A1 (es) Formulacion farmaceutica con liberacion retardada que contiene 3-(3-dimetilamino-1-etil-2-metil-propil)fenol o una sal farmaceuticamente aceptable del mismo y tabletas para administracion oral que la contienen
BR0206752A (pt) Formulação farmacêutica
CR11625A (es) Formulacion de capsula
AR065073A2 (es) Una formulacion medicamentosa de sistema de matriz que tiene liberacion controlada de un compuesto activo
GT199900203A (es) Composiciones de celecoxib.
CO6160317A2 (es) Formas de dosificacion farmaceutica no manipulables que incluyen un analgesico opioide
ES2194732T3 (es) Composiciones farmaceuticas orales de liberacion controlada de mesalazina.
PE20120584A1 (es) Preparaciones farmaceuticas transdermicas
MX2020007356A (es) Capsula de producto de higiene y sus metodos de uso.
CO4900025A1 (es) Forma de dosificacion de gelatina blanda, de fases multiples de materiales de relleno semisolidos que contienen ingre- dientes activos
AR122316A1 (es) Formulaciones de cápsulas de gel blando de origen no animal, métodos de preparación y métodos de uso de estas
ES2595354T3 (es) Sistema de polímero de silicona-sílice
AR124043A1 (es) Cápsulas blandas de liberación retardada
CR20170142A (es) Composiciones farmacéuticas resistentes al abuso
AR123800A1 (es) Composiciones de relleno para liberación sostenida y cápsulas que las contienen
CO2021012391A2 (es) Estabilidad api mejorada en capsulas blandas
ES2150404T3 (es) Composiciones farmaceuticas de tizoxanida y nitozoxanida.
Eftekhar et al. Evaluation of hydroxyl ion diffusion in dentin and injectable forms and a simple powder-water calcium hydroxide paste: An in vitro study
Reis et al. Replanted teeth stored in a newly developed powdered coconut water formula
CO4870756A1 (es) Materiales de relleno para forma de dosis farmaceutica de gelatina blanda que contienen un antiflatulento y formas farmaceuticas que las contienen